SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 2 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $4,000 | +33.3% | 516 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | +50.0% | 516 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | -60.0% | 516 | -51.0% | 0.00% | – |
Q3 2016 | $5,000 | -70.6% | 1,052 | -59.1% | 0.00% | -100.0% |
Q2 2016 | $17,000 | +6.2% | 2,570 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $16,000 | -38.5% | 2,570 | -40.1% | 0.00% | 0.0% |
Q4 2015 | $26,000 | 0.0% | 4,290 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $26,000 | 0.0% | 4,290 | +11.7% | 0.00% | 0.0% |
Q2 2015 | $26,000 | -55.2% | 3,840 | -59.5% | 0.00% | -50.0% |
Q1 2015 | $58,000 | +9.4% | 9,490 | +25.2% | 0.00% | 0.0% |
Q4 2014 | $53,000 | +39.5% | 7,580 | +60.6% | 0.00% | +100.0% |
Q3 2014 | $38,000 | -77.9% | 4,720 | -79.0% | 0.00% | -80.0% |
Q3 2011 | $172,000 | -33.6% | 22,500 | -19.6% | 0.01% | -16.7% |
Q2 2011 | $259,000 | +4.0% | 28,000 | 0.0% | 0.01% | 0.0% |
Q1 2011 | $249,000 | +29.7% | 28,000 | 0.0% | 0.01% | +20.0% |
Q4 2010 | $192,000 | – | 28,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |